Serum Albumin-Peptide Conjugates for Simultaneous Heparin Binding and Detection

Loading...
Thumbnail Image

Access rights

openAccess

URL

Journal Title

Journal ISSN

Volume Title

A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

Date

2019

Major/Subject

Mcode

Degree programme

Language

en

Pages

21891-21899

Series

ACS Omega

Abstract

Heparin is a polysaccharide-based anticoagulant agent, which is widely used in surgery and blood transfusion. However, overdosage of heparin may cause severe side effects such as bleeding and low blood platelet count. Currently, there is only one clinically licensed antidote for heparin: Protamine sulfate, which is known to provoke adverse effects. In this work, we present a stable and biocompatible alternative for protamine sulfate that is based on serum albumin, which is conjugated with a variable number of heparin-binding peptides. The heparin-binding efficiency of the conjugates was evaluated with methylene blue displacement assay, dynamic light scattering, and anti-Xa assay. We found that multivalency of the peptides played a key role in the observed heparin-binding affinity and complex formation. The conjugates had low cytotoxicity and low hemolytic activity, indicating excellent biocompatibility. Furthermore, a sensitive DNA competition assay for heparin detection was developed. The detection limit of heparin was 0.1 IU/mL, which is well below its therapeutic range (0.2-0.4 IU/mL). Such biomolecule-based systems are urgently needed for next-generation biocompatible materials capable of simultaneous heparin binding and sensing.

Description

Keywords

Other note

Citation

Liu, Q, Välimäki, S, Shaukat, A, Shen, B, Linko, V & Kostiainen, M A 2019, ' Serum Albumin-Peptide Conjugates for Simultaneous Heparin Binding and Detection ', ACS Omega, vol. 4, no. 26, pp. 21891-21899 . https://doi.org/10.1021/acsomega.9b02883